TrialReader


Ultrasound Guided Axillary Access vs Standard Fluoroscopic Technique for Cardiac Lead Implantation: ZEROFLUOROAXI TRIAL

NCT05101720 — Not applicable, Completed, 280 participants, University Hospital of Ferrara

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Ultrasound Guided Axillary Access vs Standard Fluoroscopic Technique for Cardiac Lead Implantation

RegistryNCT05101720, acronym ZEROFLUOROAXI
StatusCompleted
PhaseNot applicable
Study typeInterventional; randomized, parallel, masking: double, treatment
Enrollment280 (Actual)
SponsorUniversity Hospital of Ferrara (Other)
ConditionsArrhythmias, Cardiac, Venous Puncture, Implantable Defibrillator User, Pacemaker Complication, Vascular Access Complication, Fluoroscopy; Adverse Effect
InterventionsUltrasound Guided Axillary Venous Access, Fluoroscopy-Guided Axillary Venous Access (Procedure)
Datesstart 2021-11-01, primary completion 2022-11-30, completion 2022-12-31, first posted 2021-11-01, last updated 2023-02-08
Locations1 site in Italy

Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Arrhythmias, Cardiac All trials for Venous Puncture All trials of Ultrasound Guided Axillary Venous Access All trials of Fluoroscopy-Guided Axillary Venous Access

-Summary

Single center, randomized trial (1:1 fashion) to asses the safety and the feasibility of the ultrasound guided venous puncture vs standard fluoroscopic technique in patients undergoing pacemaker or implantable cardioverter-defibrillator implantations.

Expand all sections  ·  Collapse all

+Detailed description

Rationale: axillary, cephalic and subclavian venous accesses are commonly used in pacemaker and implantable cardioverter defibrillator implantations. Axillary puncture and cephalic vein surgical cutdown are both recommended in international guidelines due to low risk of pneumothorax and chronic lead complications. Sometimes cephalic vein is not available. Today axillary puncture is performed under fluoroscopic view and some complications still exist with this venous access as pneumothorax and arterial puncture. Axillary vein direct visualization can be obtained with standard venography or with ultrasound. With direct visualization and puncture of the axillary vein under ultrasound guidance venography with radiocontrast could be avoided. Less radiation exposure for patient and operator and direct visualization of the needle are possible with lower periprocedural complications using ultrasound. Despite the great interest for ultrasound guided axillary puncture up today we have few data on its feasibility. Our hypothesis is that ultrasound guided axillary access is more safe and more feasible than the standard fluoroscopic technique.

We decided to enroll all the patients undergoing standard transvenous pacemaker or cardioverter implantable defibrillator. We randomize the patients with 1:1 fashion to axillary venous access under fluoroscopic guidance or to ultrasound guided axillary venous access.

Obiectives: to asses safety, feasibility of the ultrasound guided venous puncture.

Main Endpoint: composite of pneumothorax, pocket hematoma, arterial puncture, pocket or device infection, hemothorax at 30 days.

+Arms and interventions

ArmTypeInterventionsDescription
Ultrasound Guided Axillary AccessExperimentalProcedure: Ultrasound Guided Axillary Venous AccessDirect visualization of axillary vein with ultrasound will be obtained and used as a guidance for venous puncture.
Fluoroscopic Guided Axillary AccessActive comparatorProcedure: Fluoroscopy-Guided Axillary Venous AccessStandard technique: using the intersection of the lateral borders of the second and third rib as a radiological landmarks.
  • Ultrasound Guided Axillary Venous Access (Procedure): Direct visualization of axillary vein will be obtained with ultrasound sterile linear probe.
  • Fluoroscopy-Guided Axillary Venous Access (Procedure): Fluoroscopic landmarks will be used and axillary venous puncture will be performed without ultrasound

+Outcome measures

Primary outcomes

  • Composite of pneumothorax, pocket hematoma, arterial puncture, pocket or device infection, hemothorax at 30 days. [One month after index procedure]: Composite of pneumothorax, pocket hematoma, arterial puncture, pocket or device infection, hemothorax at 30 days.

+Eligibility

Sex: All, ages: 18 Years to 120 Years

Inclusion Criteria:

* Need of a standard transvenous pacemaker or implantable cardioverter defibrillator implantations
* Age > 18 years

Exclusion Criteria:

* Leadless pacemaker or subcutaneous ICD

+Locations (1)

FacilityCityCountryStatus
Azienda Ospedaliero-Universitaria di FerraraFerraraItaly

+Publications

  • Results publication: Vitali F, Malagu M, Bianchi N, De Raffele M, Manfrini M, Gibiino F, Boccadoro A, Azzolini G, Balla C, Bertini M. Ultrasound-Guided Venous Axillary Access Versus Standard Fluoroscopic Technique for Cardiac Lead Implantation: ZEROFLUOROAXI Randomized Trial. JACC Clin Electrophysiol. 2024 Mar;10(3):554-565. doi: 10.1016/j.jacep.2023.11.020. Epub 2024 Jan 17. PMID 38243998

+Investigators

My Notes